Imetelstat Achieved Prolonged, Continuous Transfusion Independence (TI) in Patients with Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndrome (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESAs) within the IMerge Phase 2 Study

Platzbecker, U., Komrokji, R. S., Fenaux, P., Zeidan, A. M., Sekeres, M. A., Savona, M. R., Madanat, Y. F., Santini, V., Van Eygen, K., Raza, A., Germing, U., Berry, T., Dougherty, S., Shah, S., Sun, L., Huang, F., Feller, F., Wan, Y., Ikin, A., & Sherman, L. (2022). Imetelstat Achieved Prolonged, Continuous Transfusion Independence (TI) in Patients with Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndrome (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESAs) within the IMerge Phase 2 Study. Blood, 140(Supplement 1), 1106–1108. https://doi.org/10.1182/blood-2022-169050
Authors:
Uwe Platzbecker
Rami S. Komrokji
Pierre Fenaux
Amer M. Zeidan
Mikkael A. Sekeres
Michael R. Savona
Yazan F. Madanat
Valeria Santini
Koen Van Eygen
Azra Raza
Ulrich Germing
Tymara Berry
Souria Dougherty
Sheetal Shah
Libo Sun
Fei Huang
Faye Feller
Ying Wan
Annat Ikin
Laurie Sherman
Affiliated Authors:
Azra Raza
Columbia Affiliation:
Subjects:
Acute Myeloid Leukemia (OpenAlex Topic)
Genetic and Clinical Aspects of Hemoglobin Disorders (OpenAlex Topic)
Hematopoietic Stem Cell Biology (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2022-169050
DOI:
10.1182/blood-2022-169050
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: